Memorial Sloan Kettering Cancer Center is developing a telemedicine platform

What you should Know:

– Today, Memorial Sloan Kettering Cancer Center (MSK) announced that it has been collaborating with Accenture and Microsoft over the past 12 months to help develop and refine MSK telemedicine. MSK Telemedicine was created to provide patients with access to care during the COVID-19 pandemic and into the future, allowing MSK patients and families to virtually interact with their entire care team, seamlessly replicating a clinic visit.

– With the combined resources of Accenture, Avanade and Microsoft, MSK’s digital informatics and technology solutions team developed a standardized telemedicine platform that can be used at scale. MSK Telemedicine integrates with Microsoft Teams, which many clinicians are familiar with, while patients join appointments via a web browser, eliminating the need to download new software.

How it works

Patients receive a secure link to join MSK Telemedicine. They enter the “Virtual Clinic Room” – a virtual space where patients register, sign all necessary forms and fill out surveys. MSK care coordinators, nurses, associates, translators and other clinical team members can join the physician and patient in the virtual encounter using their existing clinical systems and telemedicine dashboard. Patients and physicians have secure access to electronic consent forms from MSK Telemedicine throughout the visit. Additionally, patients can invite family and friends for support through a secure connection, enabling a familiar and efficient care experience.